Chargement en cours...
吉非替尼治疗32例肺腺癌脑转移的临床经验
BACKGROUND AND OBJECTIVE: Brain metastasis was frequent in non-small cell lung cancer (NSCLC) patients with poor prognosis. Gefitinib was an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor which has been used in the treatment of NSCLC. Our study was to evaluate the efficacy and tox...
Enregistré dans:
| Publié dans: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
中国肺癌杂志编辑部
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000113/ https://ncbi.nlm.nih.gov/pubmed/26383979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2015.09.05 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|